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Abstract
Background: The cysteine proteinases in papaya latex have been shown to have potent anthelmintic properties in
monogastric hosts such as rodents, pigs and humans, but this has not been demonstrated in ruminants.
Methods: In two experiments, sheep were infected concurrently with 5,000 infective larvae of Haemonchus
contortus and 10,000 infective larvae of Trichostrongylus colubriformis and were then treated with the supernatant
from a suspension of papaya latex from day 28 to day 32 post-infection. Faecal egg counts were monitored from a
week before treatment until the end of the experiment and worm burdens were assessed on day 35 post-
infection.
Results: We found that the soluble fraction of papaya latex had a potent in vivo effect on the abomasal nematode
H. contortus, but not on the small intestinal nematode T. colubriformis. This effect was dose-dependent and at
tolerated levels of gavage with papaya latex (117 μmol of active papaya latex supernatant for 4 days), the H.
contortus worm burdens were reduced by 98%. Repeated treatment, daily for 4 days, was more effective than a
single dose, but efficacy was not enhanced by concurrent treatment with the antacid cimetidine.
Conclusions: Our results provide support for the idea that cysteine proteinases derived from papaya latex may be
developed into novel anthelmintics for the treatment of lumenal stages of gastro-intestinal nematode infections in
sheep, particularly those parasitizing the abomasum.
Background
The traditionally available broad-spectrum anthelmintics
for treatment of gastro-intestinal nematode infections in
ruminants are largely limited commercially to three
classes of drugs, namely benzimidazoles, imidazothia-
zoles/tetrahydropyrimidines, and macrocyclic lactones,
which have been in use extensively for some 30 to
50 years. New classes have been launched in the last few
years [1,2], represented by emodepside, monepantel, and
derquantel, but these drugs are fairly expensive and so
far have very limited label claims for efficacy. For exam-
ple, emodepside is labelled only for treatment of enteric
worms in cats, and in combination with praziquantel
tablets (Profender
®) for dogs, and monepantel and der-
quantel (in combination with abamectin) are labelled
only for use in sheep. Nonetheless, while it is likely that
s o m eo ft h e s ed r u g sm a yb el a b e l l e df o ru s ei nm o r e
species in the future, their cost will be much higher
than products of the older anthelmintic classes. Thus, it
appears most likely that the development of resistance
will continue to outpace the introduction of new anthel-
mintic drugs, and any new drugs will be much more
expensive. As a result, there is a need for more thera-
peutic agents in the market, because of the rapidity with
which resistance develops in nematodes when anthel-
mintics are applied intensively under typical large flock
industrial-scale husbandry conditions [3,4].
Natural plant-derived products have been known for
many decades to possess anthelmintic properties [5,6]
and yet generally these have been inadequately
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stage. One such group of potential anthelmintics is the
cysteine proteinases found in fruits such as papaya, figs,
kiwi fruits and pineapples. Laboratory experiments have
demonstrated clearly that these compounds damage
intestinal nematodes of rodents by a novel mechanism,
targeting the cuticle which at first blisters, and then is
disrupted and weakened sufficiently to enable the inter-
nal hydrostatic pressure t or u p t u r et h eb o d yw a l la n d
result in the disintegration of the worms [7]. Papaya
latex, which contains high concentrations of four distinct
cysteine proteinases [8], has been shown to have potent
activity against worms of the stomach, small and large
intestine in rodent model systems in vivo, causing dose-
dependent reductions of worm burdens within safe treat-
ment margins that resulted in little or no pathology
[9-11]. Fig and papaya extracts have also been shown to
reduce intestinal helminth infections in humans and in
other monogastric animals including pigs [12,13].
Ruminants pose a formidable challenge for anthelmin-
tic therapy, because after oral drenching the drugs pass
first into the rumen, where their concentrations are
greatly diluted and where they may reside for some time
before gaining access to the abomasum and remaining
sections of the intestinal tract [14]. Moreover the micro-
bial and protozoal fauna of the rumen can cause drug
efficacy to deteriorate. Indeed, papaya latex has pre-
viously been reported to have no efficacy against Hae-
monchus contortus i ns h e e p[ 1 5 ]a n dt ob eh i g h l yt o x i c
in ruminants [16].
Nevertheless, since papaya latex clearly has anthelmin-
tic activity in monogastric animals, we were interested
in reassessing the efficacy of papaya latex in sheep
infected with nematodes. H. contortus was selected,
because economically this is perhaps the most important
parasite of sheep globally, responsible for major losses to
the sheep industry [17]. We also assessed efficacy
against Trichostrongylus colubriformis,w h i c hr e s i d e si n
the mucosa of the small intestine and which therefore is
less exposed to compounds passing through the gut. In
this paper we report the results of two experiments con-
ducted in groups of lambs sufficient for robust statistical
evaluation. These studies were aimed at determining the
dose-dependence of four treatments at 24-hour inter-
vals, the efficacy of a single dose, and the impact of neu-
tralising abomasal acidity on the efficacy of papaya latex.
Materials and methods
Animals
In both experiments Greyface crosses [blueface Leicester
tups on Scottish blackface ewes] were used. They were
bred, raised and housed under conditions to minimise
parasite contamination at the Moredun Research Insti-
tute animal holding facility. Each animal was screened
for the presence of worms by faecal egg count examina-
tion prior to the start of the experimental infection. The
sheep were approximately 4-5 months-old at the time
that they were infected.
Parasites
The anthelmintic susceptible isolates of H. contortus
(MHco3; [18]) and T. colubriformis (MTco1; unpub-
lished data) were used in these trials.
Papaya latex
Four kg of Carica papaya spray-dried latex (Enzymase,
P1) were dissolved in 12 litres of water. The preparation
was centrifuged at 17,700 × g and the pellet was dis-
carded. The supernatant was concentrated to a third of
its original volume by placing in dialysis tubing [MW
cut-off 3,500 (SpectraPor 45 mm diam.)] over polyethy-
lene glycol 20,000. The concentrated material was ali-
quoted into individual containers and freeze-dried ready
for reconstitution and oral delivery. Throughout the
paper we refer to this preparation as the papaya latex
supernatant (PLS).
At each step of the purification the molar concentra-
tion of active cysteine proteinase was assessed
by titration with L-trans-epoxysuccinyl-leucylamido
(4-guanidino)- butane (E64, Sigma-Aldrich) [19] with
4 mM L-cysteine as a reducing agent. The starting
amount was 70 mmols of active enzyme in 4 kg of
spray-dried latex, and during purification 41 mmols
were retained in the freeze-dried supernatant. The indi-
vidual aliquots of freeze-dried preparation contained 47,
117 and 234 μmol active cysteine proteinase by E-64
titration, these being the individual doses used for
Experiment 1 (below). Throughout, once aliquoted and
frozen, there was no deterioration of the enzyme activity
and values derived before and after experiments were
very similar.
Haematocrit measurements
Venous blood was collected by jugular venepuncture
into 10 ml heparinised vacutainer tubes (Becton
Dickinson vacutainers systems) for microhaematocrit ana-
lysis expressed as percentage packed cell volume (PCV).
Faecal egg counts
Faecal samples were taken per rectum throughout the
course of the trial and faecal egg counts (FEC) were
conducted on the material using a modification of the
technique described by Jackson [20]. Total faecal egg
counts were differentiated into Haemonchus and Tri-
chostrongylus using previously described methodologies
[13,14]. In brief the eggs from one gram of faeces from
all individuals in each group were pooled and stained
with peanut agglutinin (PNA) lectin. The PNA lectin
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shell of H. contortus [21,22].
Necropsy and worm counts
All of the animals were necropsied on day 35 post infec-
tion (p.i.) using the post mortem and worm recovery
methods previously described [23]. The total worm bur-
dens from the abomasa and small intestines were esti-
mated from a sub-sample of the washings and saline
digests. Ten percent subsamples (500 ml) were taken
and stored.
Two percent aliquots were examined at x40 using a
stereo microscope. The data from the washings and sal-
ine digests were pooled to provide total worm burden
data. Recovered worms were sexed, staged and speciated
[24].
Cimetidine treatment
T h ea n t a c i dc i m e t i d i n e( f r o mt h eP h a r m a c ya tt h e
Queen’s Medical Centre, Nottingham) (3.2 g in 50 ml
water) was administered 20 mins before PLS in animals
that received both treatments.
Ethical approval
All experimental procedures described in this manu-
script were examined and approved by the Moredun
Research Institute Experiments and Ethics Committee
and were conducted under approved British Home
Office licenses in accordance with the Animals (Scienti-
fic Procedures) Act of 1986.
Experimental design
Two experiments were conducted. The first experiment
was designed to determine the efficacy of different
amounts of PLS administered on 4 consecutive days on
H. contortus and T. colubriformis faecal egg counts and
worm burdens (dose-response experiment). The second
experiment was split into three different sections. The
first of these was to confirm any dose-dependent effect
of PLS, the second investigated the efficacy of a single
dose compared to 4 repeat doses of PLS, and the third
examined any possible effect of an antacid, cimetidine,
and additive or synergistic effects of the co-administra-
tion of cimetidine, with PLS.
For both Experiments 1 (n =2 0 )a n d2( n =3 0 )
lambs were each infected with 5,000 infective larvae
(L3) of H. contortus and 10,000 T. colubriformis L3 on
day 0. The animals were randomly separated into
groups of five. Treatments started on day 28 p.i., and
for 3 consecutive days thereafter, aliquots of PLS pre-
parations and cimetidine, as appropriate, were recon-
stituted with 50 ml of water and delivered orally by
gavage. Animals were euthanased on day 35 p.i. unless
otherwise stated.
Experiment 1
The following treatment groups comprised Experiment 1:
Group 1 - water only, once daily for four days
Group 2 - 47 μmol active cysteine proteinase, once
daily for four days
Group 3 - 117 μmol active cysteine proteinase, once
daily for four days
Group 4 - 234 μmol active cysteine proteinase, once
daily for three days
Note: Group 4 animals only had 3 treatments and
were slaughtered on day 32 p.i.
FEC were conducted on days 21, 23, 25, 28, 29, 30, 31,
32 and 35 p.i. and on each occasion, except day 32, eggs
were differentiated as described above.
Experiment 2
This experiment comprised the following groups:
Group 1 - water only, once daily for four days
Group 2 - 50 μmol active cysteine proteinase, once
daily for four days
Group 3 - 100 μmol active cysteine proteinase, once
daily for four days
Group 4 - 100 μmol active cysteine proteinase, single
treatment
Group 5 - cimetidine 3.2 g, once daily for four days
Group 6 - cimetidine 3.2 g then 50 μmol active
cysteine proteinase, once daily for four days
FEC were conducted and eggs were differentiated as
described above.
Pathology
Immediately after euthanasia, all the carcasses were
examined for any gross lesion and samples from the
brain (internal capsule, hippocampus and midbrain)
liver, kidney, lung and rumen were collected and placed
into 10% formal saline. After fixation for five days, the
samples were processed for histopathology by standard
procedures for Haematoxylin and Eosin staining [25].
Statistical analysis
Data are presented as arithmetic means and also as Log
means [for FEC these were log10(EPG+25) and for
worm counts log10(total worms +10)] because FEC and
worm burdens are typically overdispersed in animals,
and these transformations have been found in the past
to best stabilise variance. Changes over time in FEC
were carried out on log10(EPG+25) transformed data
and analysed by repeated measures GLM (rmGLM) in
SPSS (version 16.0.0 for Windows). If the assumptions
of sphericity were not met, as assessed by Mauchley’s
test, we used the Huynh-Feldt adjustment to the degrees
of freedom to err on the side of caution.
Worm counts were analysed by non-parametric tests,
the Mann-Whitney U test for 2 group comparisons, the
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and correlational relationships were examined with
Spearman’s rank order test, all using the software pack-
age SPSS (version 16.0.0 for Windows). For testing
specific hypotheses we used the non-parametric Jonc-
khere-Terpstra test and for analyzing a 2 × 2 design the
2-way non-parametric ANOVA, both in the software
package “Asking Questions in Biology”,b a s e do n
Barnard et al [26] and on Meddis [27].
Results
Experiment 1 - Dose-response effects of papaya latex
supernatant on H. contortus and T. colubriformis
In the control group treated with water, mean undiffer-
entiated FEC values (Figure 1) were fairly steady
throughout the period of observation, with arithmetic
means varying from 6349 (±1182; standard error of the
mean) on day 21 p.i. to 12010 (±2247) on day 35 p.i.
with a peak count of 14143 (±2875) on day 31 p.i. As
can be seen from Figure 1, undifferentiated FEC in all
three groups treated with PLS showed some reduction
in the days after treatment in contrast to the water-
treated control group which rose marginally. In relation
to day 28, just prior to treatment, and based on arith-
metic means, FEC rose in the control group on day 35
by 12.0%, fell in Group 2 (47 μmol of PLS) by 66.4%
and by 74.8% in Group 3 (117 μmol of PLS). In Group
4 (234 μmol of PLS) FEC fell on day 32 by 79.4%.
Group 4 (receiving the highest dose of PLS) was culled
earlier on day 32 p.i. so that statistical analysis of FEC
was based only on the first three groups, and this indi-
cated that there was a significant main effect of treat-
ment (between subjects effect, F2,10 = 7.95, p = 0.009).
There was also a significant divergence between the
groups in FEC over time (within subjects test, 2-way
interaction time * treatment, F13.8, 69.0 = 7.43, p < 0.001).
As expected, differential FEC showed that the majority
o ft h ee g g sw e r ef r o mH. contortus,a n dt h a ti tw a st h i s
species that was primarily affected by treatment (Figure
2A; note that no differential egg counts were conducted
on day 32). As in the total FEC, there was a marked
drop after treatment that was dose-related, and in the
groups given the highest treatments, there was no sub-
sequent rise between day 31 (last day of treatment) and
autopsy on day 35.
The number of T. colubriformis eggs in faeces
dropped during the treatment period, but then picked
up soon afterwards in most groups (Figure 2C), increas-
ing by d35 even in the animals treated with 117 μmol of
active enzyme. However, in group 4, treated with
234 μmol, FEC were still low on d31 compared to ear-
lier days, a day before these animals were culled.
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Figure 1 Faecal egg counts during the course of Experiment 1.M e a ng r o u pv a l u e sb a s e do nl o g 10 (EPG+25) transformed data (± S.E.M.)
with 5 animals per group. The bold vertical arrows show the days on which treatment was administered, the first dose being given on day
28 p.i.
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highest doses of PLS cleared H. contortus worms almost
entirely from the abomasa (Figure 2B). Treatment with
117 μmol and 47 μmol resulted in 98.1% and 51.0%
reduction in worm burdens, respectively. There was a
highly significant effect of treatment (Kruskal-Wallis test,
c
2
3 = 11.57, P = 0.009 across all 4 treatment groups), that
was dose-related (rs = -0.773, n = 19, p < 0.001).
There was no significant effect of treatment on
T. colubriformis worm counts (Figure 2D) (Kruskal-
Wallis test, c
2
3 =0 . 5 5 ,p =N Sa c r o s sa l l4g r o u p s ) .
H o w e v e r ,t h ed a t ai nF i g u r e2 Ds u g g e s tt h a tT. colubri-
formis worm counts may have been lower in the group
receiving the highest dose of PLS (log mean 26.1%
lower relative to the control group) but comparison of
the worm counts in this group (Mann-Whitney U test)
with the water-treated control group gave z = -0.522,
and p = NS. The lower mean count was attributable to
two animals that had low counts (600 and 2200
worms), below the control range (5600-8700), the
other 3 being well within and even above the control
range (6950-9100).
Haematocrits
Table 1 shows that PCV were highest in the animals
treated with the highest doses of PLS, with a significant
difference between treatment groups (c
2
3 =9 . 4 ,p =
0.025). This suggests a dose-response curative effect on
haemonchosis-induced anaemia in the animals.
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Figure 2 Faecal egg counts (FEC) and worm burdens for H. contortus and T. colubriformis in Experiment 1. A, FEC attributable to
H. contortus, based on differential counts on pooled faeces at each time point, except day 32 p.i., when differential egg counts were not
conducted; B, H. contortus worm burdens; C, FEC attributable to T. colubriformis based on differential counts, as above; D, T. colubriformis worm
burdens. For details of treatments, differential counts and statistical analysis see text.
Table 1 Arithmetic mean packed cell volume (±SEM) of
sheep in treatment groups on day 31 post infection
Treatment Packed cell volume (SEM)
Water-treated control 21.5 (2.4) n =5
47 μmol active proteinase 20.3 (1.6) n =5
117 μmol active proteinase 27.9 (1.2) n =4
234 μmol active proteinase 27.4 (1.7) n =5
Buttle et al. Parasites & Vectors 2011, 4:36
http://www.parasitesandvectors.com/content/4/1/36
Page 5 of 11Pathological examination
No gross lesions were appreciated in any of the sheep
during the post-mortem studies.
Histologically, two animals showed mild focal intersti-
tial inflammatory mononuclear infiltrates in liver, lung
or rumen. There was a focal infiltration of a few mono-
nuclear cells in the alveolar wall of one animal (4636G;
234 μmol group). Only one sheep (4634G; 234 μmol
group) showed lesion in more than one organ: focal
mild infiltration of mononuclear cells in the lamina pro-
pria of the ruminal papillae and mild hypercullarity of
portal spaces in the liver.
Experiment 2
Dose-dependence of the effect of PLS given over 4 days
As Figure 3A shows, treatment with PLS resulted in an
immediate fall in FEC, and this reduction was more
marked in the sheep receiving the higher dose
(100 μmol active enzyme). The divergence between
treatment groups was significant [rmGLM on log10(EPG
+25) transformed data, within subjects test, interaction
between time and treatment, F5.4, 32.5 = 3.63, p = 0.009].
There was a significant negative correlation between
dose of active enzyme and EPGs on d35, the final day of
the experiment (rs = -0.66, n = 15, p = 0.007).
Based on the highly significant dose-response found in
Experiment 1, the hypothesis that H. contortus worm
counts should be highest in the water-treated control
group (group 1), intermediate in the animals given
50 μmol of PLS (group 2) and lowest in those treated
with 100 μmol (group 3), was tested. The results are
illustrated in Figure 3B, where it can be seen that worm
counts declined with increasing dose of treatment [non-
parametric Jonckhere-Terpstra test z =2 . 0 2( p =
0.0218)]. Based on arithmetic mean worm burdens, and
compared to the water-treated control group (4130 ±
1030) worm burdens fell by 43.6% in the group treated
with 50 μmol of PLS for 4 days (2330 ± 832) and by
79.2% (860 ± 355) in those given 100 μmol. There was a
significant negative correlation between worm counts
and increasing doses of PLS (Spearman’s one-tailed test
rs = -0.539, p = 0.019). As in Experiment 1, and as illu-
strated in Figure 3C, T. colubriformis worm burdens did
not decline with increasing dose of PLS. These results
confirm the findings of Experiment 1, namely that treat-
ment with PLS reduced H. contortus worm burdens in a
dose-dependent manner but was without effect on
T. colubriformis.
Comparison of repeated administration of PLS with a single
dose
100 μmol of active cysteine proteinase administered as a
single dose was compared with the same dose adminis-
tered on 4 consecutive days and with a water control.
Analysis of egg counts by rmGLM [duration of PLS
treatment*time, on log10(EPG+25) transformed data,
within subjects test] gave F6.0, 35.9 =5 . 0 3( p = 0.001)
when the water-treated control group was included,
indicating that FEC had diverged significantly with time
between the 3 groups (Figure 4A). However, confining
t h ea n a l y s i st ot h et w oi n f e c t e dg r o u p st oa s c e r t a i n
whether repeated administration was more effective
than a single dose treatment gave only a borderline sig-
nificance (treatment*time interaction, F2.4, 19.3 =3 . 2 1 ,
p = 0.053) and there was no significant difference
between the single dose treatment and the control
group (post-hoc test, treatment*time interaction, F1,8,=
1.26, p = 0.3). The main effect of treatment was not
significant in any of these combinations.
Sheep that had received 4 doses of PLS had fewer H.
contortus worms compared to those that had received
the single treatment (2-tailed Mann-Whitney U test, z =
-2.4, p = 0.016) (Figure 4B). However, there was no evi-
d e n c ef o rar e d u c t i o ni nw o r mb u r d e nw i t has i n g l e
treatment. The animals given a single dose of 100 μmol
of PLS had a worm burden with a higher arithmetic
mean (4080 ± 716 worms) than the water-treated con-
trols (3500 ± 1335) (Figure 4B). In respect of T. colubri-
formis worm burdens, the group given a single dose of
PLS (group 4) had a lower arithmetic mean (4590 ±
429) than the water-treated control group (group 1;
5070 ± 106) and the repeatedly treated group (group 3;
5020 ± 375), but there was no significant difference
between treated groups (Mann Whitney U test, group 3
vs group 4, z = -0.73, p = NS).
Effect of co-administration of an antacid and PLS
The co-administration of an antacid, cimetidine, with
papaya latex has been shown to greatly increase efficacy
against a murine stomach nematode [9], presumably
because of the weak activity of the papaya proteinases at
pH values ≤ 4.0 [28,29]. It has also been reported that
cimetidine had an independent anthelmintic effect when
administered directly into the abomasum [30]. We there-
fore decided to test the effect of cimetidine when admi-
nistered orally, and investigate any additive or synergistic
effect of cimetidine co-administered with a sub-optimal
dose of PLS (50 μmol active cysteine proteinase). The
F E Cd a t aa r es h o w ni nF i g u r e5 A .T h es u m m a r yd a t a
suggest that treatment with 50 μmol of active enzyme
caused a rapid, sustained drop in FEC, relative to the
control group. However, analysis by 2-way rmGLM with
PLS treatment and cimetidine treatment, as factors and
time as the within subjects factor, indicated that the
divergence of FEC between treatment groups was of bor-
derline significance only [PLS treatment *time, on log10
(EPG+25) transformed data, within subjects test, F3.5, 56.4
=2 . 5 8 9 ,p = 0.053]. There were no other significant
terms in the full factorial model, and post hoc tests on
individual days after the start of treatment did not
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Figure 3 Total FEC and individual worm burdens in sheep treated with different doses of PLS in Experiment 2. A, Total FEC. The data
are mean group values based on log10 (EPG+25) transformed data (± S.E.M.) with 5 animals per group. Repeated treatment was administered,
the first dose being given on day 28 p.i. and the last on day 31; B, H. contortus worm burdens; C, T. colubriformis worm burdens.
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treatment groups. The analysis therefore indicated that
there was no enhancement of the anthelmintic activity
when PLS was administered with the antacid cimetidine,
and no independent anthelmintic effect of cimetidine
when administered orally alone.
The results of worm counts of H. contortus are shown
in Figure 5B. The data were analyzed by a 2-way non-
parametric ANOVA. The two groups treated with PLS
had marginally lower mean worm burdens (arithmetic
means for group 2 = 2330 (±833) and group 6 = 2530
(±954), compared with group 1 = 3500 (±1335) and
group 5 = 4130 (±1030), but at this dose of enzyme
activity (50 μmol), there was no significant reduction in
worm burdens, although this was just outside the cut-
off (z =1 . 3 6 ,p = 0.087). There was no enhancement of
the anthelmintic effect in the animals co-administered
cimetidine and PLS, and there was no overall effect of
cimetidine on worm burdens.
For T. colubriformis there was no effect of PLS or of
cimetidine, given separately or in combination (worm
burdens in control group 1 = 5070 ± 10.6, and in group
2t r e a t e dw i t h5 0μmol = 5700 ± 596; the cimetidine-
treated group 5 had 5040 ± 358 worms and that given
both 50 μm o lo fP L Sa n dc i m e t i d i n e( g r o u p6 )h a d
5270 ± 362 worms).
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T h er e s u l t so ft h ep r e s e n ts t u d yd e m o n s t r a t ef o r
the first time that PLS possesses potent anthelmintic
activity capable of clearing the adult parasitic nematode
H. contortus from the sheep abomasum. The lack of effi-
c a c yo fas i n g l ed o s ec o m p a r e dw i t ht h eu s eo f4d a i l y
doses suggests that, following dilution in the rumen, the
enzymes require prolonged contact time with the
worms in order to prove effective. Our results contrast
with an earlier report of high toxicity of papaya latex in
ruminants [16]. Although two animals showed histologi-
cal lesions, they were mild and scant, and therefore
considered not significant or related to diets or treat-
ments administered to the animals. The presence of
mild inflammatory infiltrates in the digestive system,
liver or lungs is common in ruminants reared in out-
doors or semi-outdoor conditions and we therefore con-
sider them to be non-specific.
The in vivo anthelmintic efficacy of crude papaya latex
against murine nematodes residing in various parts of
the GI tract, has been reported previously [9-11]. How-
ever, in order to be able to scale up sufficiently to treat
ruminants it was necessary to find a way to concentrate
the active principles, the papaya cysteine proteinases
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Figure 5 Effect of cimetidine and PLS, administered separately or in combination, on total faecal egg counts and H. contortus worm
burdens. A, Total FEC; B, H. contortus worm burdens. Cimetidine (3.2 g) and PLS (50 μmol) were administered in isolation or in combination, on
4 consecutive days. In the latter case cimetidine was administered 20 min before PLS.
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Page 9 of 11found in the latex. A simple procedure of separation and
concentration of the supernatant fraction allowed this,
and at the same time may have removed contaminants
that are toxic in ruminants. In our experiments, no
toxic effects were detected with crude latex at effective
anthelmintic doses in mice [11] nor was there any sign
of toxicity in a pilot experiment where sheep were trea-
ted with crude latex preparations by gavage (results not
shown). It is possible to monitor accurately the molar
amount of active cysteine proteinase by the use of an
active-site titrant, E64, that binds irreversibly to the
active site of the enzymes and blocks activity, on a 1:1
molar basis [19,31]. The animals were dosed on this
basis, rather than on the weight of the crude latex.
Enzyme activity in papaya latex varies depending on the
method of its preparation as well as other factors, and a
highly active spray-dried preparation that is available in
bulk and is employed in many manufacturing processes
http://www.enzymase.com/production/process.htm was
used as our starting material.
In our experiments, the effect of PLS was dose-depen-
dent, consistent between experiments and enhanced by
repeated dosing over 4 days, but not by co-treating with
antacid (unlike earlier observations using murine sto-
mach nematodes [9]). One reas o nf o rt h el a c ko fe f f e c t
of an antacid may be the reported impact of nematode
infection on abomasal pH. Infection with Teladorsagia
(Ostertagia) circumcincta or H. contortus may lead to a
rise in abomasal pH from as low as pH 2.5 up to
approximately 6.5-7.0 [32,33], which is close to the pH
optimum of the papaya cysteine proteinases, and there-
fore there was little scope for cimetidine to alter pH
further. In our experiments abomasal pH was not moni-
tored because this would have necessitated an abomasal
fistula for the purpose and ethical approval was not
granted. The increase in abomasal pH in infected ani-
mals suggests that the enzymes would only remain
active in the abomasa in the presence of an infection,
and that in animals with no or low worm burdens the
abomasal pH would inhibit enzyme activity, thus pre-
venting any unwanted side-effects on healthy animals.
The location of T. colubriformis in the mucosa, rather
than the lumen, of the small intestine may explain its
resistance in vivo.I ti sr e l e v a n tt h a to t h e rs p e c i e so f
intestinal nematodes that have temporary developmental
stages in the tissues of their hosts are not affected by
plant cysteine proteinases during the phases of their life
cycles when they are actually in the mucosa as opposed
to the intestinal lumen [10]. Given that we found no
loss of T. colubriformis adult worms, and that we have
observed similar in vitro damage on T. colubriformis
( u n p u b l i s h e dw o r k )t ot h a tr e p o r t e db yu so no t h e r
nematodes, lack of direct and prolonged access to the
surface cuticle of T. colubriformis is the most likely
explanation for the failure of PLS to show anthelmintic
activity against this mucosal burrowing nematode. By
tunnelling through the mucosa T. colubriformis may
escape exposure to the direct effects of the cysteine pro-
teinases as these pass down the gut.
The anthelmintic mechanism of action of papaya latex
cysteine proteinases has been documented both in vitro
and in vivo in rodents. The enzymes attack as-yet
unknown protein targets in the cuticle, causing weaken-
ing of the cuticle, blistering and rupture, the release of
internal tissues leading to the death of the worm. This
property is not limited to the enzymes from papaya but
appears to be a common property of papain homologues
from pineapple, fig and from the latices of other plants
[9-11,34-37].
There remains an urgent need to develop novel
anthelmintics for controlling GI nematodes of domestic
animals, as the available agents become less effective in
the face of rapidly developing resistance by the parasites,
and livestock agriculture suffers economic stresses as a
consequence. We have suggested earlier [38] that resis-
tance to naturally occurring cysteine proteinases may be
very slow to develop, becauset h ee n z y m e sm o s tl i k e l y
target several of the constituent proteins that maintain
cuticular structure and function, and therefore resis-
tance to cysteine proteinases would be polygenic, rather
than based on single point mutations as is sometimes
the case for resistance to synthetic anthelmintics.
Although T. colubriformis proved to be unaffected by
PLS in the current experiments, many other species of
GI nematodes expose sufficient surface in the lumen of
the gut to enable contact between the parasites and the
enzymes. We predict that other, commercially important
ruminant nematode species that reside in the gut lumen
will prove to be susceptible to the action of papaya latex
cysteine proteinases, thus endowing these enzymes with
broad-spectrum activity.
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